Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0Y8SB
|
||||
Former ID |
DNC004211
|
||||
Drug Name |
L-249313
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [525962] | ||
Structure |
Download2D MOL |
||||
Formula |
C18H16N4O2
|
||||
Canonical SMILES |
CN1C=CC2=C(CN3C(=NC(=N3)C4=CC=CC=C4)C2=C1)C(=O)OC
|
||||
InChI |
1S/C18H16N4O2/c1-21-9-8-13-14(10-21)17-19-16(12-6-4-3-5-7-12)20-22(17)11-15(13)18(23)24-2/h3-10H,11H2,1-2H3
|
||||
InChIKey |
DBROFPXBIMMIMF-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Adenosine A3 receptor | Target Info | Inhibitor | [525676] | |
Adenosine A1 receptor | Target Info | Inhibitor | [525962] | ||
NetPath Pathway | TCR Signaling Pathway | ||||
RANKL Signaling Pathway | |||||
References | |||||
Ref 525676 | Bioorg Med Chem Lett. 2000 Jan 3;10(1):31-4.The utilization of a unified pharmacophore query in the discovery of new antagonists of the adenosine receptor family. | ||||
Ref 525962 | J Med Chem. 2001 Jan 18;44(2):170-9.2-Alkynyl-8-aryl-9-methyladenines as novel adenosine receptor antagonists: their synthesis and structure-activity relationships toward hepatic glucose production induced via agonism of the A(2B) receptor. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.